- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2008
- Public Summary Document (PSD) July 2008 PBAC Meeting - PDF
Doxorubicin hydrochloride – July 2008
Doxorubicin hydrochloride, pegylated liposomal, suspension for I.V. infusion, 20 mg in 10 mL and 50 mg in 25 mL, Caelyx®, July 2008
Last updated
14 November 2008